Journal Title：Cancer Investigation

Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.

《癌癥調(diào)查》是基礎(chǔ)和臨床腫瘤學(xué)領(lǐng)域最受推崇和認(rèn)可的期刊之一。它旨在為醫(yī)生提供有關(guān)癌癥領(lǐng)域當(dāng)前進(jìn)展?fàn)顩r的全面資源，以及有效決策所需的廣泛可靠信息背景。除了發(fā)表具有根本意義的原創(chuàng)論文外，它還發(fā)表評(píng)論、散文、爭議的專業(yè)介紹、新技術(shù)的考慮及其在特定實(shí)驗(yàn)室問題中的應(yīng)用、公共問題討論、主要主題的迷你系列、新藥和實(shí)驗(yàn)性藥物和療法，以及創(chuàng)新的讀者來信部分。該期刊的獨(dú)特之處之一是其部門化的編輯部分報(bào)道了 30 多個(gè)主題類別，涵蓋了構(gòu)成腫瘤學(xué)領(lǐng)域的廣泛專業(yè)領(lǐng)域。這些部分由領(lǐng)先的醫(yī)生和研究科學(xué)家編輯，使《癌癥調(diào)查》成為尋求理解整個(gè)領(lǐng)域有時(shí)令人不知所措的信息量的臨床醫(yī)生的主要資源。除了同行評(píng)審的臨床研究外，該期刊還刊登彌合實(shí)驗(yàn)室與臨床之間差距的轉(zhuǎn)化研究。

Cancer Investigation創(chuàng)刊于1983年，由Informa Healthcare出版商出版，收稿方向涵蓋醫(yī)學(xué) - 腫瘤學(xué)全領(lǐng)域，此期刊水平偏中等偏靠后，在所屬細(xì)分領(lǐng)域中專業(yè)影響力一般，過審相對較易，如果您文章質(zhì)量佳，選擇此期刊，發(fā)表機(jī)率較高。平均審稿速度 約8.5月 ，影響因子指數(shù)1.8，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。